Mechanistically, IL-22 protects against HFD-mediated inflammatory challenges and metabolic syndrome by promoting epithelium metabolism and proliferation, thus shielding protection against the gut microbiota [62]. The gene discussed is IL22; the disease is metabolic syndrome.